Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% compared to the benchmark index [3]. Core Insights - The company reported a strong performance for the year ending December 31, 2025, with total revenue of 9.18 billion yuan, a year-on-year increase of 35.1%, and a net profit of 1.15 billion yuan, up 43.7% year-on-year. The gross margin improved from 75.2% in 2024 to 76.4% in 2025, driven by an increase in the proportion of online self-operated channels and mid-to-high-end brands [1]. - The company declared a final dividend of 0.75 yuan per share for the fiscal year 2025, resulting in a total dividend payout of 498 million yuan [1]. - The brand "韩束" achieved revenue of 7.36 billion yuan in 2025, reflecting a growth of 31.6%, with significant contributions from various product lines and a user base exceeding 100 million [2]. - The "Newpage" brand saw remarkable growth, with revenue reaching 880 million yuan, a staggering increase of 134.2% [2]. - The company anticipates net profits for 2026, 2027, and 2028 to be 1.375 billion yuan, 1.681 billion yuan, and 1.941 billion yuan, respectively, with corresponding price-to-earnings ratios of 14, 12, and 10 times [3]. Financial Summary - For the fiscal year 2025, the company achieved a revenue of 9.18 billion yuan, with a year-on-year growth rate of 35.1% [5]. - The projected revenues for the years 2026 to 2028 are 11.49 billion yuan, 13.91 billion yuan, and 16.05 billion yuan, respectively, with corresponding growth rates of 25.22%, 21.06%, and 15.39% [5]. - The net profit for 2025 was 1.10 billion yuan, with a year-on-year increase of 41.14%, and is expected to grow to 1.37 billion yuan in 2026 [5].

Group 1: Liquor Industry Analysis - The report indicates that the pressure on the liquor industry has passed, with leading companies clarifying their long-term strategies and shifting from passive to proactive tactics [17][20] - The report highlights that the overall performance of the liquor industry during the Spring Festival was better than expected, with key products from leading companies showing good performance [20] - The report anticipates that the price of Moutai will stabilize above 1500 yuan, confirming the expectation of a turning point in the industry cycle [20] Group 2: Luzhou Laojiao (000568) Analysis - Luzhou Laojiao is recognized for its comprehensive competitive advantages in team capability, management level, incentive mechanisms, brand strength, product structure, and channel capabilities, positioning it as a "hexagonal warrior" in the liquor sector [3][11] - The company is expected to see its performance bottom out in the short term, with stable pricing strategies in place, aiming to reduce channel inventory and improve financial statements [11][13] - By 2030, the revenue potential for Luzhou Laojiao is projected to reach 40 billion yuan, with significant contributions from its high-end products [13][14] Group 3: Crystal International (02232) Analysis - Crystal International is positioned as a diversified international garment manufacturer, deeply integrated with top global brand clients, enhancing profitability through vertical integration [3][12] - The company is expected to benefit from a significant increase in customer orders, particularly from major clients like Uniqlo, Nike, and Adidas, while also expanding into the outdoor and sportswear sectors [12][16] - The report projects a steady increase in net profit for Crystal International from 2.5 billion to 3.0 billion USD from 2026 to 2028, with a "buy" rating assigned [16] Group 4: Shijia Photon (688313) Analysis - Shijia Photon is a leading domestic manufacturer of optical chips and devices, benefiting from the AI-driven demand for AWG and MPO products, with revenue reaching 1.56 billion yuan in the first three quarters of 2025, a year-on-year increase of 114% [3][15] - The company is expected to capitalize on the growing demand for high-density connections in AI data centers, with plans to enhance its supply chain through strategic acquisitions [15][16] - The report assigns a "buy" rating to Shijia Photon, anticipating significant revenue growth from 2.13 billion to 4.09 billion yuan from 2025 to 2027 [15][16] Group 5: Food and Beverage Industry Insights - The report concludes that the food and beverage sector is showing structural improvements, with competition shifting from price to quality, and a gradual balance in supply and demand [20] - The report emphasizes the potential for recovery in consumer prices, particularly in the liquor and food sectors, as companies adapt to changing market conditions [20] - Key recommendations include focusing on cyclical food and beverage companies with growth potential, such as Anjuke Food and Haitian Flavoring [20]

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting strong performance from key players despite a recent market downturn [2][4]. Core Insights - The cosmetics and medical beauty sector has underperformed the market recently, with the Shenwan Beauty Care Index declining by 2.4% from March 20 to March 27, 2026, compared to a 1.7% decline in the Shenwan A Index [4][5]. - Notable companies such as Maogeping, Shangmei, and Linqingxuan reported significant revenue and profit growth for 2025, with Maogeping's revenue exceeding 5 billion yuan, marking a 30% increase, and Shangmei's revenue growing by 35.1% [4][10]. - Linqingxuan achieved a remarkable revenue growth of 102.5%, doubling its revenue from 12.1 billion yuan in 2024 to 24.5 billion yuan in 2025 [16]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the overall market, with specific indices reflecting declines [4][5]. - The Shenwan Cosmetics Index fell by 2.9%, while the Shenwan Personal Care Index increased by 0.5%, indicating mixed performance within the sector [4][5]. Company Highlights - **Maogeping**: Achieved a revenue of 5.05 billion yuan in 2025, a 30% increase, with a net profit of 1.204 billion yuan, up 36.7% [10][11]. - **Shangmei**: Reported a revenue of 9.178 billion yuan, a 35.1% increase, and a net profit of 1.154 billion yuan, up 43.7% [11][12]. - **Linqingxuan**: Revenue reached 2.45 billion yuan, a 102.5% increase, with a net profit of 360 million yuan, up 92.9% [16][17]. - **Shanghai Jahwa**: Revenue of 6.317 billion yuan, an 11.25% increase, and a net profit of 268 million yuan, marking a return to profitability [20][21]. Market Trends - The report notes a strong performance in the e-commerce sector, with significant growth in online sales for major brands [27][30]. - The overall retail sales of cosmetics in China showed a growth of 4.5% in the first two months of 2026, indicating a resilient consumer demand [30][31]. Strategic Recommendations - The report recommends focusing on companies with strong brand matrices and high growth in GMV, such as Maogeping and Shangmei, while also highlighting potential in the mother and baby segment [4][10]. - It suggests monitoring companies with strong R&D capabilities and product pipelines in the medical beauty sector, such as Aimeike and Langzi [4][10].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The company achieved a revenue of 9.18 billion yuan in 2025, representing a year-on-year growth of 35.1%, and a net profit attributable to shareholders of 1.1 billion yuan, up 41.1% year-on-year [5] - The company continues to expand its multi-brand strategy, with significant contributions from brands such as Han Shu and Newpage [9][10] - The gross profit margin improved to 76.4%, an increase of 1.2 percentage points year-on-year, while the operating cash flow grew significantly by 120.3% [8] Financial Performance - In 2025, the company reported a revenue of 9.18 billion yuan, with a net profit of 1.1 billion yuan and an EPS of 2.77 yuan [5] - The revenue for the first half of 2025 was 4.11 billion yuan, growing 17.3% year-on-year, while the second half saw a revenue of 5.07 billion yuan, up 54.1% [5] - The company plans to distribute a cash dividend of 0.75 yuan per share [5] Brand Performance - Han Shu and Newpage brands saw revenue growth of 31.6% and 134.2% respectively, with Han Shu contributing 80.2% to total revenue [6] - The online sales channel accounted for 93.9% of total revenue, with a year-on-year growth of 40.1% [7] Future Projections - The company forecasts revenues of 11.02 billion yuan, 13.47 billion yuan, and 16.16 billion yuan for 2026, 2027, and 2028 respectively, with corresponding net profits of 1.33 billion yuan, 1.63 billion yuan, and 1.98 billion yuan [11] - The report anticipates a continued focus on multi-brand strategies to drive growth and improve operational efficiency [9][10]

Group 1 - Investment Rating: Buy (Initiating Coverage) [1] - Core Viewpoint: The report analyzes the rapid rise of the Han Shu brand and how Shangmei Co., Ltd. is advancing towards a multi-brand strategy [7][8] - Revenue and Profit Growth: The company has achieved significant revenue and profit growth, with a projected revenue of 91.72 billion, 111.55 billion, and 134.07 billion yuan for 2025-2027, representing year-on-year growth of 35%, 22%, and 20% respectively [8] Group 2 - Market Data: As of March 23, 2026, the current price is HKD 58.40, with a total market capitalization of approximately 23.25 billion HKD [4] - Performance Relative to Hang Seng Index: Over the past 12 months, Shangmei Co., Ltd. has outperformed the Hang Seng Index with a 35% increase compared to the index's 2.9% increase [5] - Brand Matrix Formation: The company is forming a strong brand matrix with Han Shu as the leading brand, contributing significantly to revenue growth [20] Group 3 - Multi-Channel Strategy: The company has established a comprehensive multi-channel strategy, leveraging platforms like Douyin for marketing and sales [10][20] - Product Innovation: The introduction of new products like the Hong Man Yao series has driven brand upgrades and sales growth [38] - R&D Investment: The establishment of research centers and collaboration with scientists has enhanced product development and innovation capabilities [34]

Group 1 - China Coal Australia (03668.HK) maintains a "Buy" rating with a target price of HKD 38, benefiting from rising natural gas prices due to Middle East geopolitical conflicts, which may drive coal prices up, enhancing profitability by 5% for every 1% increase in coal prices [1] - Aubo Holdings (00880.HK) holds a "Neutral" rating with a target price of HKD 2.20, facing short-term market share pressure and a 3% decline in EBITDA margin due to the closure of satellite entertainment venues, but is working on property upgrades to attract customers [1] - Neway Group (01686.HK) is upgraded to a "Buy" rating with a target price of HKD 8.58, as its MEGA IDC phase one has a 91% occupancy rate, and demand for AI reasoning and high-density deployment is significantly increasing [1] Group 2 - JD Group (09618.HK) receives a "Strong Buy" rating, with Q4 retail operating profit down only 2.5% year-on-year, better than expected, and a recovery in food delivery losses, alongside double-digit growth in daily necessities and 3P advertising revenue [2] - JD Logistics (02618.HK) maintains a "Buy" rating, with Q4 non-IFRS net profit up 5.7%, driven by significant internal revenue growth of 68% from instant delivery, and the privatization of Debon is expected to accelerate network integration and profitability recovery [2] Group 3 - China Tobacco Hong Kong (06055.HK) holds a "Buy" rating, with a projected 14.8% year-on-year growth in net profit for 2025, and a 6.2 percentage point increase in H2 cigarette export gross margin to 21.4%, attributed to channel expansion and product optimization [3] Group 4 - Bilibili-W (09626.HK) maintains a "Buy" rating, with Q4 DAU up 10% to 113 million, and advertising revenue increasing by 27%, driven by improved ad efficiency and AIGC tool applications, achieving annual profitability for the first time [4] Group 5 - Bosideng (03998.HK) holds a "Buy" rating, achieving mid-single-digit revenue growth despite a warm winter, with brand strength reinforced through designer series and successful international expansion [5] Group 6 - Swire Properties (01972.HK) maintains a "Buy" rating, with 67% completion of its HKD 100 billion investment plan, and a projected 9% CAGR for mainland IP rights area by 2032, showcasing strong financial health and stable dividend growth [6] Group 7 - Shangmei Co. (02145.HK) holds a "Buy" rating, with projected revenue growth of 34.0%-35.4% and net profit growth of 41.9%-44.4% for 2025, driven by strong sales of popular product lines and healthy channel structure [7]

Investment Rating - The report maintains a "Buy" rating for the company [2][7] Core Insights - The company has exceeded expectations with strong revenue and profit growth, indicating continuous improvement in profitability quality [7] - The multi-brand strategy is yielding results, with the core brand Han Shu leading growth and new brands like NewPage emerging as significant contributors [7] - The company is focused on a "single focus, multi-brand, globalization" strategy, aiming for long-term growth and expansion into international markets [7] Financial Data and Profit Forecast - Revenue projections for 2023 to 2027 are as follows: - 2023: 4,191 million - 2024: 6,793 million - 2025E: 9,109 million - 2026E: 10,942 million - 2027E: 12,617 million - Year-on-year growth rates for revenue are projected at 57% for 2023, 62% for 2024, 34% for 2025, 20% for 2026, and 15% for 2027 [6][8] - Net profit attributable to shareholders is forecasted as follows: - 2023: 461 million - 2024: 781 million - 2025E: 1,154 million - 2026E: 1,452 million - 2027E: 1,738 million - The net profit growth rates are projected at 213% for 2023, 69% for 2024, 48% for 2025, 26% for 2026, and 20% for 2027 [6][8]

Core Insights - The domestic beauty brand Han Shu is currently facing challenges, including a controversy over product ingredients and executive turnover, which reflects broader scrutiny in the beauty industry [1][3][4] Group 1: Ingredient Controversy - Han Shu's two facial mask products were reported by CCTV to contain epidermal growth factor (EGF), leading to public concern despite the company's claims of compliance [4][6] - EGF is primarily used in medical applications, and its use in cosmetics is prohibited in China due to safety concerns, prompting Han Shu to withdraw the affected products and issue a statement asserting no EGF was added [6][9] - The discrepancy between testing results from CCTV and Han Shu's own tests raises questions about the detection methods used, highlighting the lack of standardized testing for EGF in cosmetics [7][8] Group 2: Business Performance and Strategy - Han Shu has experienced significant growth, with revenue reaching 5.591 billion yuan in 2024, marking over a threefold increase in two years, making it a key driver for its parent company, Shangmei [10][11] - The brand's strategy of focusing on single products and leveraging platforms like Douyin has led to its dominance in the beauty sector, achieving a GMV of 33.4 billion yuan in 2023 [11][13] - However, the company's reliance on Han Shu, which accounted for 82.3% of revenue in 2024, poses risks, as any issues with the brand could directly impact overall performance [15][16] Group 3: Market Challenges and Future Directions - The growth rate of Han Shu has begun to slow, with a 14.3% increase in revenue for the first half of 2025, indicating a need for transformation and diversification [17][18] - To reduce dependency on Han Shu, Shangmei is accelerating the development of multiple brands, with new brand Newpage achieving a revenue of 397 million yuan in the first half of 2025, growing by 146.5% [18][20] - The company is also pursuing globalization, entering Southeast Asian markets with tailored products, but faces challenges in brand recognition and local market adaptation [20][21] Group 4: Innovation and Long-term Goals - The shift from a marketing-driven approach to a technology-driven strategy is crucial for Han Shu to enhance its product offerings and address consumer skepticism regarding domestic brands [21][22] - The company aims to achieve a revenue target of 10 billion yuan by 2025, with ongoing investments in research and development to support this goal [21][22]

Core Viewpoint - The crisis surrounding Up Beauty Co., Ltd. continues to escalate, with significant stock price fluctuations and allegations of illegal additives in its products, particularly affecting its core brand, Han Shu [1][2][10]. Stock Performance - On December 30, Up Beauty's stock fell by 2.5%, closing at HKD 72.2, marking a total decline of over 15% over two days [1]. - The stock experienced a sharp drop on December 29, reaching a low of HKD 57, a decline of over 33% during the trading session [1]. Product Controversy - Han Shu's products were found to contain epidermal growth factor (EGF), which is not permitted in cosmetics due to safety concerns [2]. - Following the allegations, Han Shu removed the affected products from e-commerce platforms and issued a statement denying the presence of EGF in its products [2][4]. Consumer Reaction - Consumers have expressed distrust and demanded refunds, citing concerns over the safety of the products after the illegal additive allegations [4]. - Previous incidents of illegal additives in Han Shu products have raised further doubts about the brand's integrity [9]. Financial Performance - In the first half of 2025, Han Shu contributed approximately 81.4% of Up Beauty's revenue, amounting to CNY 3.344 billion, a 14.3% increase year-on-year [10]. - The company's online self-operated channel revenue reached CNY 3.421 billion, a 24.6% increase, with its share of total revenue rising from 78.4% to 83.3% [10]. Marketing Strategy - Up Beauty has heavily invested in marketing, particularly through collaborations with influencers and short dramas, leading to a significant increase in revenue [10][11]. - However, this strategy has resulted in rising marketing expenses, with the sales expense ratio increasing from 47.01% in 2022 to 56.88% in the first half of 2025, while R&D spending has decreased [11]. Strategic Shift - The company is shifting its strategic focus towards other brands, aiming for a pre-tax sales target of CNY 4.36 billion for 2026, with specific targets for brands like NEW PAGE and Anminyou [12][13]. - Concerns remain regarding the feasibility of these targets, given the current revenue performance of these brands [13].

Core Viewpoint - The market for new consumption in Hong Kong has shifted from a focus on short-term GMV growth to evaluating long-term operational capabilities, brand resilience, and research barriers of companies, with Up Beauty Co., Ltd. (02145) exemplifying this trend through a significant stock price increase of 150% year-to-date, reaching a new high of 104 HKD [1] Group 1: Multi-Brand Strategy - Up Beauty has abandoned the old model of betting on a single blockbuster product/brand, adopting a multi-brand matrix to meet diverse consumer needs, transitioning from "traffic support" to "user cultivation" [2] - The core brand, Han Shu, has maintained rapid growth, leading the mass skincare market and achieving high sales across multiple platforms, including being the top beauty brand on Douyin during the 2025 Double Eleven shopping festival [2][3] - The brand new page has emerged as a significant growth driver, with a total sales increase of 145% year-on-year during the 2025 Double Eleven, showcasing strong performance across various channels [3] Group 2: Channel Synergy and Category Extension - The crowded skincare market has made "category extension" a key path for domestic beauty brands to unlock growth potential, with domestic brands having an advantage in understanding local consumer needs [5] - Up Beauty has successfully entered new categories such as men's skincare and personal care, leveraging the brand value of Han Shu to educate the market and convert profits [6] - The company's full-channel strategy has enhanced sales performance, with significant growth in GMV across platforms like Douyin, Tmall, and JD during the 2025 Double Eleven [7] Group 3: Research and Development - R&D investment has shifted from a cost item to a value item, with Up Beauty's R&D spending exceeding 1.03 billion CNY in the first half of 2025, reflecting a 31.7% year-on-year increase [8] - The company has established a robust R&D system, including nearly 200 patents and participation in setting national standards, enhancing its market influence [9] - Core ingredients developed by Up Beauty, such as cyclic hexapeptide-9 and X-peptide, have become competitive advantages, allowing for higher profit margins and differentiation in a crowded market [9] Group 4: Long-term Growth Narrative - Up Beauty's strategic focus on a multi-brand matrix, full-channel strategy, and long-term R&D investment positions it well for sustainable growth in the evolving consumption landscape [10] - The company's transformation from a "traffic-driven" to a "value-driven" entity is attracting long-term capital interest, with significant potential for continued growth and value creation in the Hong Kong new consumption wave [10]